A Merck KGaA brand logo stands in front of the company premises. WuXi Biologics, a Chinese biopharmaceuticals company, announced on 06 January the sale of its WuXi Vaccines facility in Ireland to ...
LabConnect remains committed to creating healthier communities by supporting our clients in successfully developing new ...
Contentious hearings to consider Robert F. Kennedy Jr. to lead the Department of Health and Human Services this week have ...
View of Moderna company office entrance exterior with logo sign in Cambridge ... Moderna's partnership with Merck on a cancer vaccine shows potential, but it is years away from generating ...
ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, ...
Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Merck (MRK) to $106 from $113 and keeps an Equal Weight rating on the ...
Merck (MRK) is down -10.8%, or -$10.74 to $89.05.Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, ...
Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.
The drugmaker’s guidance was affected by a pause in shipments of its top-selling vaccine to China from February through at ...
Merck said it will pause shipments of Gardasil to China through at least mid-year, as continued weak demand for the HPV ...
Rob Davis emphasized Merck's strong performance in 2024, driven by demand for KEYTRUDA, the launch of WINREVAIR, and robust growth in Animal Health. Davis highlighted challenges in GARDASIL sales in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback